• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Severe Jaundice in a COVID-19 Patient-Virus or Drug?

作者信息

Jothimani Dinesh, Vij Mukul, Sanglodkar Uday, Patil Vaibhav, Sachan Deepti, Narasimhan Gomathy, Kaliamoorthy Ilankumaran, Rela Mohamed

机构信息

Institute of Liver Disease and Transplantation, Dr Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India.

Department of Transfusion Medicine, Institute of Liver Disease and Transplantation, Dr Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India.

出版信息

J Clin Exp Hepatol. 2021 May-Jun;11(3):407-408. doi: 10.1016/j.jceh.2021.02.006. Epub 2021 Feb 25.

DOI:10.1016/j.jceh.2021.02.006
PMID:33654344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7906515/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40da/8103313/e27f9824fb8b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40da/8103313/e27f9824fb8b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40da/8103313/e27f9824fb8b/gr1.jpg

相似文献

1
Severe Jaundice in a COVID-19 Patient-Virus or Drug?一名新冠肺炎患者出现的严重黄疸——是病毒还是药物所致？
J Clin Exp Hepatol. 2021 May-Jun;11(3):407-408. doi: 10.1016/j.jceh.2021.02.006. Epub 2021 Feb 25.
2
[80-year-old patient with jaundice after a severe Covid-19 infection].[一名80岁的患者在严重的新冠病毒感染后出现黄疸]
Dtsch Med Wochenschr. 2021 Jan;146(1):13-14. doi: 10.1055/a-1264-4718. Epub 2021 Jan 4.
3
Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection.原发性EB病毒感染所致重型肝炎中病毒感染T细胞的关联
J Clin Virol. 2006 Mar;35(3):250-6. doi: 10.1016/j.jcv.2005.07.009. Epub 2005 Sep 21.
4
Dual Infection with Hepatitis B and Epstein-Barr Virus Presenting with Severe Jaundice, Coagulopathy, and Hepatitis B Virus Chronicity Outcome.乙型肝炎与爱泼斯坦-巴尔病毒双重感染伴严重黄疸、凝血功能障碍及乙型肝炎病毒慢性化结局
Am J Case Rep. 2017 Feb 16;18:170-172. doi: 10.12659/ajcr.901688.
5
A case of severe cholestatic jaundice with hyperthyroidism successfully treated with methimazole.1例严重胆汁淤积性黄疸合并甲状腺功能亢进症患者用甲巯咪唑成功治愈。
Clin J Gastroenterol. 2009 Aug;2(4):315-319. doi: 10.1007/s12328-009-0094-8. Epub 2009 Jun 17.
6
[Severe hepatitis and jaundice during the evolution of dengue virus infection: case report].[登革病毒感染病程中出现的重症肝炎和黄疸：病例报告]
Rev Soc Bras Med Trop. 2010 May-Jun;43(3):339-41. doi: 10.1590/s0037-86822010000300026.
7
Prolonged Jaundice in a Patient with Coexisting Hepatitis A Virus Infection and Wilson's Disease.甲型肝炎病毒感染与肝豆状核变性共存患者的迁延性黄疸。
Mymensingh Med J. 2021 Apr;30(2):559-561.
8
Severe and prolonged oral contraceptive jaundice.重度及持续性口服避孕药所致黄疸
J Clin Gastroenterol. 1984 Apr;6(2):145-8. doi: 10.1097/00004836-198404000-00009.
9
Jaundice following bone marrow transplantation. The problem of diagnosis.骨髓移植后的黄疸。诊断问题。
S Afr Med J. 1983 Jul 16;64(3):84-9.
10
Successful treatment of fosinopril-induced severe cholestatic jaundice with plasma exchange.血浆置换成功治疗福辛普利引起的严重胆汁淤积性黄疸。
Ann Pharmacother. 2008 Dec;42(12):1887-92. doi: 10.1345/aph.1L229. Epub 2008 Nov 18.

引用本文的文献

1
Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.特应性药物性肝损伤问题的研究进展：由于使用 Roussel Uclaf 因果关系评估方法，新的临床和机制分析。
Int J Mol Sci. 2023 Jun 29;24(13):10855. doi: 10.3390/ijms241310855.
2
Post-COVID-19 cholangiopathy: Current understanding and management options.新冠后胆管病：当前的认识与管理选择
World J Gastrointest Surg. 2023 May 27;15(5):788-798. doi: 10.4240/wjgs.v15.i5.788.
3
Treatment of Drug-Induced Liver Injury.

本文引用的文献

1
Pathogenesis of Liver Injury in Coronavirus Disease 2019.2019冠状病毒病肝损伤的发病机制
J Clin Exp Hepatol. 2020 Nov-Dec;10(6):641-642. doi: 10.1016/j.jceh.2020.05.006. Epub 2020 May 20.
2
Oral anticoagulants and risk of acute liver injury in patients with nonvalvular atrial fibrillation: a propensity-weighted nationwide cohort study.口服抗凝剂与非瓣膜性心房颤动患者急性肝损伤的风险：一项倾向评分加权的全国性队列研究。
Sci Rep. 2020 Jul 15;10(1):11624. doi: 10.1038/s41598-020-68304-8.
3
COVID-19 and the liver.COVID-19 与肝脏。
药物性肝损伤的治疗
Biomedicines. 2022 Dec 21;11(1):15. doi: 10.3390/biomedicines11010015.
4
Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.COVID-19 患者药物性肝损伤：基于 RUCAM 因果关系评估方法，对 2020/2021 年发表的 996 例 DILI 病例的系统评价。
Int J Mol Sci. 2022 Apr 27;23(9):4828. doi: 10.3390/ijms23094828.
J Hepatol. 2020 Nov;73(5):1231-1240. doi: 10.1016/j.jhep.2020.06.006. Epub 2020 Jun 15.
4
Cholestatic liver injury as a side-effect of dabigatran and the use of coagulation tests in dabigatran intoxication and after reversal by idarucizumab in bleeding and sepsis.作为达比加群的副作用，出现胆汁淤积性肝损伤，以及在出血和脓毒症时应用idarucizumab逆转达比加群抗凝作用后，检测凝血试验的应用。
Scand J Clin Lab Invest. 2018 Feb-Apr;78(1-2):1-5. doi: 10.1080/00365513.2017.1402127. Epub 2017 Nov 17.
5
Drug Hepatotoxicity: Newer Agents.药物性肝毒性：新型药物。
Clin Liver Dis. 2017 Feb;21(1):115-134. doi: 10.1016/j.cld.2016.08.009. Epub 2016 Oct 14.